Share Twitter LinkedIn Facebook Email Michael B. Atkins at Georgetown Lombardi Comprehensive Cancer Center, Scholl Professor and Vice Chair Department of Oncology follows up on the long-term Checkmate-004 in metastatic melanoma and provides outcomes from the study.
What Are the Latest Melanoma Treatment Advances? [87 Slides] Justin Moyers, MD Melanoma and Skin 3 Mins Read
AMTAGVI [lifileucel] FDA Approved Game-Changer in Melanoma Treatment? Here’s What You Need to Know. Melanoma and Skin 5 Mins Read
Long and Short Term Toxicity Management in Immuno-Oncology – MOASC [2023] – Katy Tsai, MD Melanoma and Skin 2 Mins Read